Statement of Retraction: Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial
- PMID: 31830835
- DOI: 10.1080/14767058.2019.1703527
Statement of Retraction: Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial
Retraction of
-
Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial.J Matern Fetal Neonatal Med. 2018 Feb;31(3):388-394. doi: 10.1080/14767058.2017.1286315. Epub 2017 Feb 15. J Matern Fetal Neonatal Med. 2018. Retraction in: J Matern Fetal Neonatal Med. 2020 Mar;33(6):1073. doi: 10.1080/14767058.2019.1703527. PMID: 28114846 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources